Expert Review of Clinical Pharmacology

Papers
(The TQCC of Expert Review of Clinical Pharmacology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Strategies for lowering lipoprotein(a): a spotlight on novel pharmacological treatments196
Personalizing tamoxifen therapy in adjuvant therapy: a brief summary of the ongoing discussion57
Why is diagnosis, investigation, and improved management of kidney stone disease important? Non-pharmacological and pharmacological treatments for nephrolithiasis46
Renin angiotensin aldosterone inhibitors in the treatment of proteinuria in children with congenital anomalies of the kidney and urinary tract: more evidence needed41
Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis39
Therapeutic drug monitoring of antiretroviral therapy: current progresses and future directions34
What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion31
Management of polypharmacy through deprescribing in older patients: a review of the role of AI tools31
Sodium-glucose cotransporter 2 inhibitors in frail, older people with type 2 diabetes and heart failure: do we have enough evidence to confidently support the use?31
Clinical pharmacology of antiplatelet drugs30
Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome30
Effects of the augmentation with quetiapine or olanzapine on the metabolism of duloxetine: a retrospective analysis28
Reducing the risk of death – a possible outcome in COPD patients28
Prostate cancer and novel pharmacological treatment options–what’s new for 2022?28
JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review27
Sparsentan: a dual endothelin and angiotensin II receptor antagonist approved for IgA nephropathy26
The pharmacotherapeutics of sarcoidosis26
Dostarlimab for the treatment of advanced endometrial cancer24
Fetal safety of medications used in treating infertility23
Amylin analogs for the treatment of obesity without diabetes: present and future23
Role of tenecteplase in ischemic stroke after 4.5 hours: an evaluation of the TRACE-III trial21
Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy20
Clinical efficacy and safety of topical difamilast in the treatment of patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials20
Hugan tablets for the treatment of RUCAM based drug-induced liver injury: a propensity score matching analysis using a nationwide database20
Cannabidiol drug interaction considerations for prescribers and pharmacists20
Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection20
Nicotine e-cigarettes for smoking cessation: a clinical pharmacology perspective19
Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study19
The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease19
Reply to: The risk for genito-urinary infections with sodium-glucose cotransporter-2 inhibitors: duration rather than dose matter?18
Nirmatrelvir/Ritonavir and molnupiravir: an update on COVID-19 antivirals in the Omicron era18
Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients18
Pharmacological strategies for the management of the antisocial personality disorder17
Recent pharmacological approaches for the treatment of renal cell carcinoma17
Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis17
Effect of laparoscopic sleeve gastrectomy on drug pharmacokinetics16
OPTIMA-ID: development and validation of a medicine optimization tool for older adults with intellectual disability16
Melflufen for the treatment of multiple myeloma16
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape16
Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis16
Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management16
Hydroxyurea in the sickle cell disease modern era16
Methenamine Hippurate in UTI management: a reemerging pharmacological strategy14
Population pharmacokinetic modeling and exposure-response analysis of anrikefon: insights and implications in clinical analgesia14
A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy14
Current status and prospects of IL-6–targeting therapy14
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)14
Clozapine for older adults with severe mental illness: a systematic review and expert recommendations for clinical practice14
Clinical pharmacology of SGLT-2 inhibitors in heart failure14
Pharmacogenomics – a minor rather than major force in clinical medicine13
Methotrexate polyglutamates13
A systematic review and meta-analysis of users versus non-users: unveiling the influence of proton pump inhibitors on capecitabine efficacy in colorectal cancer12
Early response is a strong predictor of the long-term response in psoriasis patients receiving risankizumab or guselkumab in the real-world: a retrospective analysis12
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis12
FLOT vs CROSS in localized esophageal adenocarcinoma: what is the current best strategy?12
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia12
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review12
Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of adalimumab in patients with juvenile idiopathic arthritis11
Antimicrobial safety considerations in critically ill patients: part II: focused on anti-microbial toxicities11
Phosphatidylinositol 3 kinase inhibitor-related pneumonitis: a systematic review and meta-analysis11
Revolutionizing diabetes care: unveiling tirzepatide’s potential in glycemic control and beyond11
An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry11
Risk factors for a broken heart: understanding drug-induced causes for Takotsubo syndrome and pharmacological treatment options11
Designer benzodiazepines: an update11
Efficacy and safety of tislelizumab for malignant solid tumor: a systematic review and meta-analysis of phase III randomized trials11
The nocebo phenomenon in the COVID-19 pandemic: a nocebodemic effect11
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review10
Biomarker discovery in acetaminophen hepatotoxicity: leveraging single-cell transcriptomics and mechanistic insight10
Pharmacokinetic interaction of quetiapine and lamotrigine – victim and perpetrator?10
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysis10
Optimization of secukinumab dose regimens in patients with moderate-to-severe plaque psoriasis via exposure-response modeling10
Recent advances in the pharmacological management of sepsis-associated acute kidney injury10
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis10
Clinical pharmacology of siRNA therapeutics: current status and future prospects9
Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future9
Interstitial lung disease associated with anti-HER2 anti-body drug conjugates: results from clinical trials and the WHO's pharmacovigilance database9
Reliance is key to effective access and oversight of medical products in case of public health emergencies9
Pharmacological and safety profile of a prolonged-release lanreotide formulation in acromegaly9
Genito-urinary infectious adverse events related to sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression9
TYK2 as a novel therapeutic target in psoriasis9
Signal mining study of severe cutaneous adverse events of valaciclovir or acyclovir based on the FAERS database9
Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-up9
Dasiglucagon for treating severe hypoglycemia in patients with diabetes9
Advances in pharmacokinetic-pharmacodynamic modelling for pediatric drug development: extrapolations and exposure-response analyses9
Opioid use disorder in pediatric populations: considerations for perioperative pain management and precision opioid analgesia8
Practical challenges and considerations in adopting biosimilars in oncology clinical practice within a large healthcare system8
Clinical outcomes of oral anticoagulant discontinuation in atrial fibrillation: a systematic review and meta-analysis8
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock8
Current understanding of the etiology of cyclic vomiting syndrome and therapeutic strategies in its management8
Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system8
Clozapine for treatment refractory catatonia in individuals with autism spectrum disorder: a retrospective chart review study8
Adverse clinical outcomes associated with drug-related hospitalizations in people with dementia8
The future of pharmacology education: The Veterinary Educators in Pharmacology Special Interest Group (VEPSIG)8
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause8
Keeping up with venetoclax for leukemic malignancies: key findings, optimal regimens, and clinical considerations8
Antimicrobial safety considerations in critically ill patients: part I: focused on acute kidney injury8
Quantitative effects of sodium-glucose cotransporter-2 inhibitors on liver functions in patients with nonalcoholic fatty liver disease7
Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria7
Treatment and prevention of influenza in geriatric patients7
Biosimilar development and review process in the BRICS-TM countries: Proposal for a standardized model to improve regulatory performance7
Considerations when prescribing opioid agonist therapies for people living with HIV7
Availability and evaluation of medication management resources for carers of people with dementia: a scoping review with an environmental scan7
Pharmacological treatment for transforming growth factor beta induced corneal dystrophies: what is the way forward?7
Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to suppor7
Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants7
The impact of pregnancy-related hormonal and physiological changes on antiseizure medications: expert perspective7
Implementing pharmacogenetics in clinical trials: considerations about current methodological, ethical, and regulatory challenges7
Novel and emerging treatment strategies for lupus nephritis7
Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin7
Optimizing outcomes and managing adverse events in locally advanced or metastatic urothelial cancer: a clinical pharmacology perspective7
Hormonal contraception, past, present, and future part 1: the early path – facts, stories, and controversies7
Detrimental impact of gastric acid suppressants on vascular endothelial growth factor receptor tyrosine kinase inhibitors efficacy: evidence from a systematic review and meta-analysis7
131-I-metaiodobenzylguanidine and chemotherapy for advanced neuroblastoma7
Extending the ambit of SGLT2 inhibitors beyond diabetes: a review of clinical and preclinical studies on non-diabetic kidney disease7
The changes of IgE levels in type 2 inflammatory diseases after treatment of dupilumab: a systematic review and meta-analysis7
Intravitreal immunotherapy in non-infectious uveitis: an update7
Intraperitoneal therapy for gastric cancer peritoneal carcinomatosis7
Blinding and expectancy confounds in psychedelic randomized controlled trials7
Inhaler technique in asthma and COPD: challenges and unmet knowledge that can contribute to suboptimal use in real life7
0.052860021591187